Latest news
Scholar Rock Reports Second Quarter 2026 Financial Results and Recent Business Highlights - Business WireBusiness Wire · Thu, 06 Aug 2026 11:00:00 GMTVedanta Biosciences Secures $60 Million in Funding and Strengthens Leadership Team Ahead of Pivotal Phase 3 Data - Business WireBusiness Wire · Thu, 06 Aug 2026 11:00:00 GMTAmylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results - Business WireBusiness Wire · Thu, 06 Aug 2026 11:00:00 GMTU.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1 - Business WireBusiness Wire · Wed, 05 Aug 2026 22:10:00 GMTDream Industrial REIT Reports Strong Q2 2026 Results and 2.5% Distribution Increase - Business WireBusiness Wire · Tue, 04 Aug 2026 22:57:00 GMTObsidian Therapeutics Completes Closing of Transaction with Galera Therapeutics and Previously Announced Private Placement of $350 Million - Business WireBusiness Wire · Mon, 03 Aug 2026 13:00:00 GMTU.S. FDA Grants Orphan Drug Designation to Zai Lab’s DLL3-Targeting ADC Zocilurtatug Pelitecan (Zoci) for the Treatment of Neuroendocrine Carcinomas (NECs) - Business WireBusiness Wire · Mon, 03 Aug 2026 11:00:00 GMTCambridge Savings Bank Supports Belle Brands' Acquisition of Versed Through Increased Credit Facility - Business WireBusiness Wire · Wed, 29 Jul 2026 07:00:00 GMT